Oxazinanes
Aobchem 2 3-Dihydro- -phenyl-1H-indene-4-methanol | 95% | CAS 201486-99-9 | C16H16O | 500mg
2 3-Dihydro- -phenyl-1H-indene-4-methanol | 95% | CAS 201486-99-9 | C16H16O | 500mg
Aobchem Ethanone 2-chloro-2-fluoro-1-(4-fluorophenyl)- | 97% | CAS 395-32-4 | C8H5ClF2O | 1g
Ethanone 2-chloro-2-fluoro-1-(4-fluorophenyl)- | 97% | CAS 395-32-4 | C8H5ClF2O | 1g
Aobchem Ethanone 2-chloro-2-fluoro-1-(4-fluorophenyl)- | 97% | CAS 395-32-4 | C8H5ClF2O | 500mg
Ethanone 2-chloro-2-fluoro-1-(4-fluorophenyl)- | 97% | CAS 395-32-4 | C8H5ClF2O | 500mg
Aobchem 7-(Methylthio)-3 4-dihydro-2H-benzo[b][1 4]dioxepine | 95% | CAS 1090985-67-3 | C10H12O2S | 1g
7-(Methylthio)-3 4-dihydro-2H-benzo[b][1 4]dioxepine | 95% | CAS 1090985-67-3 | C10H12O2S | 1g
![Aobchem 6-Bromo-3 4-dihydro-2H-benzo[b][1 4]dioxepine | 95% | CAS 1279822-61-5 | C9H9BrO2 | 5g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000998624.png-250.jpg)
Aobchem 6-Bromo-3 4-dihydro-2H-benzo[b][1 4]dioxepine | 95% | CAS 1279822-61-5 | C9H9BrO2 | 5g
6-Bromo-3 4-dihydro-2H-benzo[b][1 4]dioxepine | 95% | CAS 1279822-61-5 | C9H9BrO2 | 5g
Aobchem 1-(2-Fluoro-4-morpholinophenyl)ethanone | 95% | CAS 870850-30-9 | C12H14FNO2 | 500mg
1-(2-Fluoro-4-morpholinophenyl)ethanone | 95% | CAS 870850-30-9 | C12H14FNO2 | 500mg
Aobchem 1-(5-Iodoindolin-1-yl)ethanone | ≥97% | CAS 61995-51-5 | C10H10INO | 5g
1-(5-Iodoindolin-1-yl)ethanone | ≥97% | CAS 61995-51-5 | C10H10INO | 5g
Aobchem (2 3-Difluorophenyl)(morpholino)methanone | ≥97% | CAS 351038-43-2 | C11H11F2NO2 | 1g
(2 3-Difluorophenyl)(morpholino)methanone | ≥97% | CAS 351038-43-2 | C11H11F2NO2 | 1g
Aobchem 6-Bromo-5-fluoro-2-methyl-2H-indazole | ≥95% | CAS 1286734-87-9 | C8H6BrFN2 | 10g
6-Bromo-5-fluoro-2-methyl-2H-indazole | ≥95% | CAS 1286734-87-9 | C8H6BrFN2 | 10g
Aobchem 5-Bromo-2-(phenylmethyl)-2H-indazole | ≥97% | CAS 937049-51-9 | C14H11BrN2 | 500mg
5-Bromo-2-(phenylmethyl)-2H-indazole | ≥97% | CAS 937049-51-9 | C14H11BrN2 | 500mg
Cayman Chemical Cl-Amidine (hydrochloride), Purity: ≥95%, CAS: 1373232-26-8, 1 mg
A PAD inhibitor (IC50s = 0.8, 6.2, and 5.9 µM for PAD1, PAD3, and PAD4, respectively); cytotoxic to HL-60, MCF-7, and HT-29 cancer cells (IC50s = 0.25, 0.05, and 1 μM, respectively); reduces ex vivo extracellular NET formation and increases survival in a mouse model of CLP-induced sepsis at 50 mg/kg; decreases the citrulline content in serum and joints and reduces the development of IgG autoantibodies in a mouse model of collagen-induced arthritis
Cayman Chemical CP 24,879 (hydrochloride), Purity: ≥98%, CAS: 10141-51-2, 5 mg
A Δ5/Δ6 desaturase inhibitor; reduces liver arachidonate content by ~50% in mice at 3 mg/kg; increases mead acid content and inhibits leukotriene C4 synthesis in murine mastocytoma cells at 5 µM
Cayman Chemical FR122047 (hydrochloride), Purity: ≥98%, CAS: 130717-51-0, 1 mg
A selective COX-1 inhibitor (IC50 = 0.028 µM for the human enzyme); selective for COX-1 over COX-2 (IC50 = 65 µM); inhibits arachidonic acid, collagen, and ADP-induced platelet aggregation in human platelet-rich plasma (IC50 = 180-200 nM); unlike aspirin, it does not induce gastric damage at 100 mg/kg, p.o.; has an anti-inflammatory effect in a rat models of collagen-induced arthritis
Cayman Chemical DL-threo-PDMP (hydrochloride), Purity: ≥98%, CAS: 80938-69-8, 100 mg
An inhibitor of sphingolipid biosynthesis; inhibits glucosylceramide synthase by 33 and 48% in MDCK cell homogenates at 5 and 10 µM; reduces the synthesis of glucosylceramide increases cellular ceramide, and induces cell cycle arrest; increases Aβ42 and Aβ39 production independent of ceramide metabolism via modulation of γ-secretase activity